Source: Annual Congress 2004 - Developments in the management of lower respiratory tract infections



Rating:

Share or cite this content

Citations should be made in the following way:
M. Niederman (Mineola, United States Of America). Treatment guidelines for CAP and the role of macrolides. Annual Congress 2004 - Developments in the management of lower respiratory tract infections

Member's Comments

No comment yet.

Related content which might interest you: CAP and HAP guidelines: treatment indications and more Source: Annual Congress 2006 - PG1 - Respiratory infections: pneumonia/antibiotic resistance and clinical outcome of lower respiratory tract infections Year: 2006 Antimicrobial Treatment of CAP. Is there a higher benefit of macrolides combination in patients with pneumococcal CAP? Source: International Congress 2017 – Update on community acquired pneumonia Year: 2017 International Guideline concordance of empiric antibiotic use in community-acquired pneumonia Source: Virtual Congress 2020 – Antibiotic therapy for pneumonia and pleural infections Year: 2020 Impact of guidelines on HAP and VAP outcomes Source: Eur Respir Mon 2011; 53: 66-73 Year: 2011 Antibiotic treatment considerations beyond guidelines Source: International Congress 2017 – Management of Hospital-Acquired Pneumonia (HAP)/Ventilator-associated pneumonia (VAP) Year: 2017 Community acquired pneumonia guidelines: not only treatment indications Source: Annual Congress 2004 - PG22 - New perspectives in pneumonia treatment and prophylaxis Year: 2004 Dynamic of adherence to guidelines for antibiotic therapy of community-aquired pneumonia (CAP) Source: Annual Congress 2013 –Antibiotics, resistance and vaccines Year: 2013 Adherence to guidelines' empirical antibiotic recommendations and community-acquired pneumonia outcome Source: Eur Respir J 2008; 32: 892-901 Year: 2008 Adherence to guidelines and clinical stability in community-acquired pneumonia Source: Eur Respir J 2004; 24: Suppl. 48, 241s Year: 2004 International guidelines for nosocomial pneumonia: do they cover multidrug resistance management? Source: International Congress 2019 – Multidrug resistance in nosocomial pneumonia: burden, magnitude and solution Year: 2019 Can CAP guideline adherence improve patient outcome in internal medicine departments? Source: Eur Respir J 2008; 32: 902-910 Year: 2008 Potential protective role of prior to diagnosis antibiotic treatment in community-acquired pneumonia: Clinical presentation and outcomes Source: Annual Congress 2011 - Antimicrobial treatment and resistance in lower respiratory tract infections Year: 2011 Implementation of severity guided antibiotic treatment according to Dutch guidelines in hospitalized patients with community-acquired pneumonia (CAP) included in a clinical trial Source: Annual Congress 2011 - Antimicrobial treatment and resistance in lower respiratory tract infections Year: 2011 Influence of adherence to clinical guidelines in empiric antibiotics choice on outcomes of community-acquired pneumonia in hospitalized Belarussian patients Source: Eur Respir J 2005; 26: Suppl. 49, 637s Year: 2005 Survival benefit of beta-lactam plus macrolide combined therapy versus beta-lactam plus quinolones in hospitalized community-acquired pneumonia Source: International Congress 2016 – Community-acquired pneumonia: update on prognostic factors and therapeutic strategies Year: 2016 Evaluation of severity score-guided approaches to macrolide use in community-acquired pneumonia Source: Eur Respir J, 50 (3) 1602306; 10.1183/13993003.02306-2016 Year: 2017 Monotherapy with β-lactamic antibiotics or macrolides vs their combination for the treatment of community acquired pneumonia (CAP) Source: Annual Congress 2008 - Lower respiratory tract infection: from outbreak to prognostic tests Year: 2008 Tigecycline vs levofloxacin for the treatment of community-acquired pneumonia (CAP): EU experience Source: Annual Congress 2008 - Treatment and outcome in hospitalised patients with community-acquired pneumonia Year: 2008 Relevance of correct antibiotic choice in community-acquired pneumonia (CAP) Source: Annual Congress 2005 - Community-acquired pneumonia: clinical approaches Year: 2005 Guideline adherence in treatment of COPD Source: Annual Congress 2010 - Management of airway disease Year: 2010